ARCHIVES

ODAC Recommends Fludarabine Approval for Refractory CLL

This article is from The Cancer Letter archive.

Vol. 16 No. 36 | September 21, 1990

Download PDF Visit The Full Archive

Related Articles

FDA carries Action On Two Cancer Drugs Over To 1996

January 5, 1996

Centers Network Release “Version 1.0” Of Clinical Guidelines for Eight Cancers

March 15, 1996

Study Explores Reasons Women Avoid Mammograms

February 25, 2011

Capitol Hill: Trial Results Represent Culmination of Research, Klausner Tells House

March 19, 1999

Lilly Made False Claims About Ralozifene Reducing Breast Cancer risk, Judge Rules

July 30, 1999

NCAB Jolted By 1977 Prelim Budget, “Outrageous” Prospect – Funding Only 30% Of Approved Grants

June 27, 1975